Trailing-twelve-month (TTM) revenue is $31.26 Million with a year-over-year growth of +24.07%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $6,346,992 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-22 |
| Q3 FY2026Period ended 2025-12-31 | $6,224,776 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-21 |
| Q4 FY2026Period ended 2026-03-31 | $7,654,806 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q1 FY2027Period ended 2026-06-30 | $11,034,057 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-22 |
| TTM revenue | $31,260,631 |
Current P/S: $566,929,399 market capitalization ÷ $31,260,631 TTM revenue = 18.14x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:28.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $11.03M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:17:51.876Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2018-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-03-31 · USD | FY20192019-03-31 · USD | FY20202020-03-31 · USD | FY20212021-03-31 · USD | FY20222022-03-31 · USD |
|---|---|---|---|---|---|
| Contract Research and Development | $3M | $1M | $1M | $825,689 | $1M |
| Product | $27M | $25M | $24M | $21M | $26M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20132013-03-31 · USD | FY20142014-03-31 · USD | FY20152015-03-31 · USD | FY20162016-03-31 · USD | FY20182018-03-31 · USD |
|---|---|---|---|---|---|
| Asia | $4M | $3M | $4M | $3M | N/A |
| Asia Pacific | N/A | N/A | N/A | N/A | $5M |
| EMEA |
$31.26M
$31.26 Million
+24.07%
vs. $25.20M a year ago (TTM)
+5.49%
5 Year compound annual growth rate
1 Year
+24.07%
3 Year
(7.69%)
5 Year
+5.49%
10 Year
+1.82%
15 Year
+0.07%
20 Year
+4.57%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $26.33M | +$456,524 | +1.76% |
| 2025 | $25.87M | ($3.93M) | (13.18%) |
| 2024 | $29.80M | ($8.45M) | (22.09%) |
| 2023 | $38.25M | +$11.27M | +41.75% |
| 2022 | $26.99M | +$5.62M | +26.31% |
| 2021 |
TTM Growth
+24.07%
3-Year CAGR
(7.69%)
5-Year CAGR
+5.49%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:17:51.876Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| N/A |
| $10M |
| Europe | $11M | $11M | $14M | $11M | N/A |
|---|
| Other Areas | N/A | N/A | N/A | $819,695 | N/A |
|---|
| Rest of World | N/A | N/A | N/A | N/A | $211,678 |
|---|
| U | $12M | $11M | $12M | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | $12M | $15M |
|---|
| $21.37M |
| ($4.05M) |
| (15.92%) |
| 2020 | $25.41M | ($1.06M) | (4.00%) |
| 2019 | $26.47M | ($3.39M) | (11.36%) |
| 2018 | $29.86M | +$1.54M | +5.43% |
| 2017 | $28.33M | +$608,918 | +2.20% |
